Net Cash Provided by (Used in) Operating Activities in USD of Regen BioPharma Inc from Q4 2014 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Regen BioPharma Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from Q4 2014 to Q4 2024.
- Regen BioPharma Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Dec 2024 was -$66.4K, a 59.1% increase year-over-year.
- Regen BioPharma Inc annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$752K, a 332% decline from 2023.
- Regen BioPharma Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$174K, a 71.3% increase from 2022.
- Regen BioPharma Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$607K, a 46.3% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)